Nako e tloaelehileng ea ho hoama ha 'mele oa motho e fapana ho latela mokhoa oa ho lemoha.
Tse latelang ke mekhoa e 'maloa e tloaelehileng ea ho lemoha le mefuta ea tsona e tloaelehileng ea litšupiso:
1 Nako e sebetsang ea karolo ea thromboplastin (APTT):
Sebaka se tloaelehileng sa litšupiso hangata ke metsotsoana e 25-37. APTT e bonts'a haholo-holo mosebetsi oa likarolo tsa ho kopanya VIII, IX, XI, XII, jj. tseleng ea ho kopanya ea ka hare.
2 Nako ea Prothrombin (PT):
Boleng bo tloaelehileng ba referense hangata ke metsotsoana e 11-13. PT e sebelisoa haholo-holo ho lekola mosebetsi oa likarolo tsa coagulation II, V, VII, X, jj. tseleng ea extrinsic coagulation.
3 Karolelano ea Machaba e tloaelehileng (INR):
Mefuta e tloaelehileng ea litšupiso e pakeng tsa 0.8 le 1.2. INR e baloa ho latela boleng ba PT 'me e sebelisoa ho lekola phello ea kalafo ea li-anticoagulant tsa molomo (joalo ka warfarin) ho etsa hore liphetho tsa liteko lipakeng tsa lilaboratori tse fapaneng li bapisoe.
4 Fibrinogen (FIB):
Tekanyo e tloaelehileng ea litšupiso ke 2-4g/L. FIB ke glycoprotein ea plasma e entsoeng ke sebete 'me e bapala karolo ea bohlokoa ts'ebetsong ea ho hoama. E fetoloa fibrin tlas'a ts'ebetso ea thrombin ho etsa lehlomela la mali.
Ho lokela ho hlokomeloa hore lisebelisoa tsa liteko le li-reagent tsa lilaboratori tse fapaneng li ka fapana, 'me boleng bo itseng ba litšupiso bo ka fapana hanyane. Ho phaella moo, lintlha tse ling tsa 'mele (tse kang lilemo, bong, boimana, jj.) le lintlha tsa pathological (tse kang lefu la sebete, mafu a tsamaiso ea mali, ho nka meriana e itseng, jj.) le tsona li tla ama nako ea ho koala mali. Ka hona, ha ho hlalosoa liphetho tsa nako ea ho koala mali, tlhahlobo e felletseng e hloka ho etsoa hammoho le boemo bo itseng ba mokuli.
BEIJING SUCCEEDER TECHNOLOGY INC.
Tlhahlobo ea ho kopana ha mahloriso le tebeletso ea mahloriso
KOPO EA LITŠEBELETSO TSA SEHLAHLOBI
Beijing Succeeder Technology Inc. (khoutu ea setoko: 688338) e 'nile ea ameha ka botebo lefapheng la tlhahlobo ea ho koala ha mali ho tloha ha e thehoa ka 2003, 'me e ikemiselitse ho ba moetapele lefapheng lena. Ntlo-kholo ea eona e Beijing, k'hamphani e na le sehlopha se matla sa R&D, tlhahiso le thekiso, se shebaneng le boqapi le ts'ebeliso ea theknoloji ea tlhahlobo ea thrombosis le hemostasis.
Ka matla a eona a ikhethang a botekgeniki, Succeeder e hapile litokelo tsa molao tse 45 tse lumelletsoeng, ho kenyeletsoa litokelo tsa molao tse 14 tsa boqapi, litokelo tsa molao tse 16 tsa mohlala oa utility le litokelo tsa molao tse 15 tsa moralo. Khamphani e boetse e na le mangolo a 32 a ngoliso ea lihlahisoa tsa bongaka tsa Sehlopha sa II, mangolo a 3 a ho faela a Sehlopha sa I, le setifikeiti sa EU CE bakeng sa lihlahisoa tse 14, 'me e fetile setifikeiti sa sistimi ea taolo ea boleng ba ISO 13485 ho netefatsa bokhabane le botsitso ba boleng ba sehlahisoa.
Succeeder ha se feela kgwebo ya bohlokwa ya Morero wa Ntshetsopele ya Leapfrog Industry Leapfrog wa Beijing Biomedicine (G20), empa hape e atlehile ho fihlella Boto ya Ntjhafatso ya Saense le Theknoloji ka 2020, e fihlella ntshetsopele e phahameng ya khamphani. Hona jwale, khamphani e hahile marangrang a thekiso naheng ka bophara a akaretsang baemedi le diofisi tse makgolo. Dihlahiswa tsa yona di rekiswa hantle dikarolong tse ngata tsa naha. E boetse e ntse e atolosa mebaraka ya mose ho mawatle ka mafolofolo mme e ntse e ntlafatsa tlhodisano ya yona ya matjhaba ka ho tswela pele.
Karete ea khoebo
WeChat ea Sechaena